Arash O Naghavi1, Michelle I Echevarria2, Tobin J Strom2, Yazan A Abuodeh2, Kamran A Ahmed2, Puja S Venkat2, Andy Trotti2, Louis B Harrison2, B Lee Green3, Kosj Yamoah2, Jimmy J Caudell4. 1. H. Lee Moffitt Cancer Center and Research Institute, Department of Radiation Oncology, Tampa, FL, United States. Electronic address: Arash.naghavi@moffitt.org. 2. H. Lee Moffitt Cancer Center and Research Institute, Department of Radiation Oncology, Tampa, FL, United States. 3. H. Lee Moffitt Cancer Center and Research Institute, Department of Health Outcomes and Behavior, Tampa, FL, United States. 4. H. Lee Moffitt Cancer Center and Research Institute, Department of Radiation Oncology, Tampa, FL, United States. Electronic address: jimmy.caudell@moffitt.org.
Abstract
PURPOSE: Patient race has been shown to predict for differences in outcomes and has been attributed to socioeconomic factors such as social support and access to healthcare. In head and neck cancer (HNC), a disease without recommended screening, we sought to investigate the association between race, treatment delays and outcome. METHODS: Records of 1802 patients with non-metastatic squamous cell HNC treated between 1998 and 2013 were retrospectively assessed from an institutional database. Patient demographics, tumor and treatment characteristics, and patient outcomes were abstracted from the chart. Differences between groups were assessed via logistic regression multivariate analysis (MVA). Outcomes including locoregional control (LRC) and overall survival (OS) were then estimated via Kaplan-Meier and Cox-regression MVA. RESULTS: Median follow up was 34 months. Patient races included white (n=1671, 93%), black (n=80, 4%), Asian (n=18, 1%), and other (n=33, 2%). On logistic regression MVA, Black patients were less likely to be married (39% vs. 63%; OR 0.5 95%CI 0.30-0.83, p=0.007) or be currently employed (43% vs. 61%; OR 0.44 95%CI 0.26-0.74, p=0.002) when compared to non-blacks. Black patients were also younger (54 vs. 59 years, p=0.001), more likely to present with advanced tumor stage (T4: 48% vs. 25%), and more often had >45days elapsed from diagnosis to treatment initiation (DTI) (61% vs. 49%, p=0.028). Delays in treatment, such as delayed diagnosis (advanced disease presentation) and delays in DTI>45days were also associated with marital and employment status. Black patients were associated with a lower 3-year LRC rate (65% vs. 81%, p<0.001) and OS rate (43% vs. 69%, p<0.001), compared to non-black patients. Patients with >45days DTI had a detriment in 3-year LRC (77% vs. 83%, p=0.002) and OS (66% vs. 69%, p=0.009). On Cox MVA, black race was independently prognostic for worse LRC (HR 1.62 95%CI 1.04-2.51, p=0.033) and OS (HR 1.55 95%CI 1.15-2.08, p=0.004) vs. non-blacks. CONCLUSION: Black race is independently prognostic for LRC and OS. Delays in HNC treatment, such as more advanced tumor stage presentation and delays in treatment initiation, may be attributed to socioeconomic factors such as employment status and social support. Efforts to accommodate these factors may expedite treatment, in hopes of improving the race related outcome disparity in HNC. Copyright Â
PURPOSE:Patient race has been shown to predict for differences in outcomes and has been attributed to socioeconomic factors such as social support and access to healthcare. In head and neck cancer (HNC), a disease without recommended screening, we sought to investigate the association between race, treatment delays and outcome. METHODS: Records of 1802 patients with non-metastatic squamous cell HNC treated between 1998 and 2013 were retrospectively assessed from an institutional database. Patient demographics, tumor and treatment characteristics, and patient outcomes were abstracted from the chart. Differences between groups were assessed via logistic regression multivariate analysis (MVA). Outcomes including locoregional control (LRC) and overall survival (OS) were then estimated via Kaplan-Meier and Cox-regression MVA. RESULTS: Median follow up was 34 months. Patient races included white (n=1671, 93%), black (n=80, 4%), Asian (n=18, 1%), and other (n=33, 2%). On logistic regression MVA, Black patients were less likely to be married (39% vs. 63%; OR 0.5 95%CI 0.30-0.83, p=0.007) or be currently employed (43% vs. 61%; OR 0.44 95%CI 0.26-0.74, p=0.002) when compared to non-blacks. Black patients were also younger (54 vs. 59 years, p=0.001), more likely to present with advanced tumor stage (T4: 48% vs. 25%), and more often had >45days elapsed from diagnosis to treatment initiation (DTI) (61% vs. 49%, p=0.028). Delays in treatment, such as delayed diagnosis (advanced disease presentation) and delays in DTI>45days were also associated with marital and employment status. Black patients were associated with a lower 3-year LRC rate (65% vs. 81%, p<0.001) and OS rate (43% vs. 69%, p<0.001), compared to non-black patients. Patients with >45days DTI had a detriment in 3-year LRC (77% vs. 83%, p=0.002) and OS (66% vs. 69%, p=0.009). On Cox MVA, black race was independently prognostic for worse LRC (HR 1.62 95%CI 1.04-2.51, p=0.033) and OS (HR 1.55 95%CI 1.15-2.08, p=0.004) vs. non-blacks. CONCLUSION: Black race is independently prognostic for LRC and OS. Delays in HNC treatment, such as more advanced tumor stage presentation and delays in treatment initiation, may be attributed to socioeconomic factors such as employment status and social support. Efforts to accommodate these factors may expedite treatment, in hopes of improving the race related outcome disparity in HNC. Copyright Â
Authors: S Tribius; M S Meyer; C Pflug; H Hanken; C-J Busch; A Krüll; C Petersen; C Bergelt Journal: Strahlenther Onkol Date: 2018-05-07 Impact factor: 3.621
Authors: Ronica Nanda; David Boulware; Rachid Baz; Diane Portman; H Michael Yu; Heather Jim; Peter A S Johnstone Journal: Acta Oncol Date: 2020-06-04 Impact factor: 4.089
Authors: Tyler A Janz; Joanne Kim; Elizabeth G Hill; Katherine Sterba; Graham Warren; Anand K Sharma; Terry A Day; Chanita Hughes-Halbert; Evan M Graboyes Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-12-01 Impact factor: 6.223
Authors: Sean T Massa; Nosayaba Osazuwa-Peters; Eric Adjei Boakye; Ronald J Walker; Gregory M Ward Journal: JAMA Otolaryngol Head Neck Surg Date: 2019-03-01 Impact factor: 6.223
Authors: Anvesh Kompelli; Kathleen B Cartmell; Katherine R Sterba; Anthony J Alberg; Christopher C Xiao; Amit J Sood; Elizabeth Garrett-Mayer; Shai J White-Gilbertson; Steven A Rosenzweig; Terry A Day Journal: World J Otorhinolaryngol Head Neck Surg Date: 2020-03-05
Authors: Michael M Li; Songzhu Zhao; Antoine Eskander; Chandler Rygalski; Guy Brock; Anuraag S Parikh; Catherine T Haring; Brian Swendseid; Kevin Y Zhan; Carol R Bradford; Theodoros N Teknos; Ricardo L Carrau; Kyle K VanKoevering; Nolan B Seim; Matthew O Old; James W Rocco; Sidharth V Puram; Stephen Y Kang Journal: Ann Surg Oncol Date: 2021-07-15 Impact factor: 4.339
Authors: Suleyman Y Goksu; Muhammet Ozer; Syed M A Kazmi; Todd A Aguilera; Chul Ahn; David Hsiehchen; Aravind Sanjeevaiah; Mary C Maxwell; Muhammad S Beg; Nina N Sanford Journal: Am J Clin Oncol Date: 2020-11 Impact factor: 2.787